GlaxoSmithKline
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has GlaxoSmithKline's balance sheet done over the years? Its assets were worth $60,146,000,000 last year, which is less than in the previous period. 83% of GlaxoSmithKline’s total assets is currently financed by debt. Its liabilities reached the amount of $50,050,000,000, which means an decrease by -13% compared compared to last year.
Debt to Assets
| 2013 | 42086000000 | 34.27B | 81.44% |
|---|---|---|---|
| 2014 | 40651000000 | 35.71B | 87.86% |
| 2015 | 53446000000 | 44.56B | 83.39% |
| 2016 | 59081000000 | 54.11B | 91.6% |
| 2017 | 56381000000 | 52.89B | 93.81% |
| 2018 | 58066000000 | 54.39B | 93.68% |
| 2019 | 79692000000 | 61.33B | 76.97% |
| 2020 | 80431000000 | 59.62B | 74.13% |
| 2021 | 79103000000 | 57.76B | 73.02% |
| 2022 | 60146000000 | 50.05B | 83.21% |
GSK.SW Balance Sheet (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 3.72B | 4.27B | 6.09B | 4.70B | 3.87B | 3.83B | 4.89B | 5.83B | 4.33B | 5.53B |
Short term investments | 4.15B | 61M | 78M | 79M | 84M | 78M | 89M | 75M | 69M | 66M |
Net receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory | 5.14B | 5.78B | 5.99B | 5.94B | 5.47B | 5.55B | 5.10B | 4.71B | 4.23B | 3.9B |
Other current assets | 7.74B | 8.55B | 8.08B | 8.75B | 7.49B | 6.43B | 6.62B | 5.96B | 6.04B | 5.72B |
Total current assets | 20.76B | 18.67B | 20.24B | 19.49B | 16.92B | 15.90B | 16.71B | 16.58B | 14.67B | 15.22B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 9.62B | 10.67B | 11.00B | 11.31B | 11.05B | 10.86B | 10.80B | 9.66B | 9.05B | 8.87B |
Goodwill | 7.04B | 10.55B | 10.59B | 10.56B | 5.78B | 5.73B | 5.96B | 5.16B | 3.72B | 4.20B |
Intangible assets | 14.31B | 30.07B | 29.82B | 30.95B | 17.20B | 17.56B | 18.77B | 16.67B | 8.32B | 9.28B |
Long term investments | -2.61B | 2.15B | 3.34B | 2.07B | 1.47B | 1.02B | 1.15B | 1.38B | 1.38B | 1.45B |
Other non-current assets | 5.34B | 1.75B | 1.12B | 1.20B | 1.72B | 1.49B | 1.28B | 1.06B | 804M | 956M |
Total non-current assets | 39.37B | 60.42B | 60.18B | 60.20B | 41.13B | 40.47B | 42.37B | 36.85B | 25.97B | 26.85B |
Total assets | 60.14B | 79.10B | 80.43B | 79.69B | 58.06B | 56.38B | 59.08B | 53.44B | 40.65B | 42.08B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Short term debt | 3.95B | 3.60B | 3.72B | 6.91B | 5.79B | 2.82B | 4.12B | 1.30B | 2.94B | 2.78B |
Total current liabilities | 22.81B | 23.67B | 22.14B | 24.05B | 22.49B | 26.56B | 19.00B | 13.41B | 13.29B | 13.67B |
| Non-current liabilities: | ||||||||||
Long term debt | 17.03B | 20.57B | 23.42B | 23.59B | 20.27B | 14.26B | 14.66B | 15.32B | 15.84B | 15.45B |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 9.91B | 9.96B | 10.42B | 9.86B | 10.45B | 19.97B | 27.39B | 26.72B | 16.68B | 15.06B |
Total non-current liabilities | 27.24B | 34.09B | 37.47B | 37.28B | 31.90B | 26.32B | 35.11B | 31.15B | 22.42B | 20.59B |
Total liabilities | 50.05B | 57.76B | 59.62B | 61.33B | 54.39B | 52.89B | 54.11B | 44.56B | 35.71B | 34.27B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |